99 related articles for article (PubMed ID: 21493295)
1. Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma.
Sang-Hyuk Lee SH; Lee NH; Jin SM; Rho YS; Jo SJ
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):64-70. PubMed ID: 21493295
[TBL] [Abstract][Full Text] [Related]
2. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
3. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers.
Kannan S; Yokozaki H; Jayasree K; Sebastian P; Mathews A; Abraham EK; Nair MK; Tahara E
Int J Oral Maxillofac Surg; 2002 Aug; 31(4):414-8. PubMed ID: 12361076
[TBL] [Abstract][Full Text] [Related]
4. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
5. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
6. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
8. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of APC and CDH1 genes in laryngeal squamous cell carcinoma.
Pećina-Slaus N; Kljaić M; Nikuseva-Martić T
Pathol Res Pract; 2005; 201(8-9):557-63. PubMed ID: 16259108
[TBL] [Abstract][Full Text] [Related]
12. [Epidermoid carcinoma of the cervix uteri: molecular abnormalities of p53 and rb genes].
Wistuba I; Capurro I
Rev Med Chil; 1996 May; 124(5):553-60. PubMed ID: 9035506
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
[TBL] [Abstract][Full Text] [Related]
15. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
16. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.
Sourvinos G; Kazanis I; Delakas D; Cranidis A; Spandidos DA
J Urol; 2001 Jan; 165(1):249-52. PubMed ID: 11125419
[TBL] [Abstract][Full Text] [Related]
17. [Loss of heterozygosity in esophageal squamous cell carcinoma and its precursor lesion].
Wang QH; Zhang PH; Li G; Cong J; Hu N
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):346-9. PubMed ID: 15363321
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
19. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma.
Pećina-SLaus N; Gall-TroSelj K; SLaus M; Radić K; NikuSeva-Martić T; Pavelić K
Pathology; 2004 Apr; 36(2):145-51. PubMed ID: 15203750
[TBL] [Abstract][Full Text] [Related]
20. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
